These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 24457615)

  • 1. Myostatin and sarcopenia: opportunities and challenges - a mini-review.
    White TA; LeBrasseur NK
    Gerontology; 2014; 60(4):289-93. PubMed ID: 24457615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice.
    Camporez JP; Petersen MC; Abudukadier A; Moreira GV; Jurczak MJ; Friedman G; Haqq CM; Petersen KF; Shulman GI
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2212-7. PubMed ID: 26858428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propeptide-mediated inhibition of myostatin increases muscle mass through inhibiting proteolytic pathways in aged mice.
    Collins-Hooper H; Sartori R; Macharia R; Visanuvimol K; Foster K; Matsakas A; Flasskamp H; Ray S; Dash PR; Sandri M; Patel K
    J Gerontol A Biol Sci Med Sci; 2014 Sep; 69(9):1049-59. PubMed ID: 24414825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function.
    Murphy KT; Koopman R; Naim T; Léger B; Trieu J; Ibebunjo C; Lynch GS
    FASEB J; 2010 Nov; 24(11):4433-42. PubMed ID: 20624929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms in aging and current strategies to counteract sarcopenia.
    Sakuma K; Yamaguchi A
    Curr Aging Sci; 2010 Jul; 3(2):90-101. PubMed ID: 20158492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myostatin is associated with age-related human muscle stem cell dysfunction.
    McKay BR; Ogborn DI; Bellamy LM; Tarnopolsky MA; Parise G
    FASEB J; 2012 Jun; 26(6):2509-21. PubMed ID: 22403007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged absence of myostatin reduces sarcopenia.
    Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
    J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia: current theories and the potential beneficial effect of creatine application strategies.
    Candow DG
    Biogerontology; 2011 Aug; 12(4):273-81. PubMed ID: 21373890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength.
    Arounleut P; Bialek P; Liang LF; Upadhyay S; Fulzele S; Johnson M; Elsalanty M; Isales CM; Hamrick MW
    Exp Gerontol; 2013 Sep; 48(9):898-904. PubMed ID: 23832079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regenerative decline of stem cells in sarcopenia.
    Sousa-Victor P; Muñoz-Cánoves P
    Mol Aspects Med; 2016 Aug; 50():109-17. PubMed ID: 26921790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention.
    Brioche T; Pagano AF; Py G; Chopard A
    Mol Aspects Med; 2016 Aug; 50():56-87. PubMed ID: 27106402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults.
    Angulo J; El Assar M; Rodríguez-Mañas L
    Mol Aspects Med; 2016 Aug; 50():1-32. PubMed ID: 27370407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting the inevitability of ageing.
    Drew L
    Nature; 2018 Mar; 555(7695):S15-S17. PubMed ID: 29517046
    [No Abstract]   [Full Text] [Related]  

  • 14. Understanding of sarcopenia: from definition to therapeutic strategies.
    Kim JW; Kim R; Choi H; Lee SJ; Bae GU
    Arch Pharm Res; 2021 Oct; 44(9-10):876-889. PubMed ID: 34537916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun NH2-terminal kinase, Notch, and Akt signaling pathways.
    Kovacheva EL; Hikim AP; Shen R; Sinha I; Sinha-Hikim I
    Endocrinology; 2010 Feb; 151(2):628-38. PubMed ID: 20022929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myostatin blockade therapy for muscular atrophy].
    Sunada Y
    Brain Nerve; 2011 Nov; 63(11):1271-7. PubMed ID: 22068480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of sarcopenia research.
    Janssen I
    Appl Physiol Nutr Metab; 2010 Oct; 35(5):707-12. PubMed ID: 20962927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle mass and plasma myostatin after exercise training: a substudy of Renal Exercise (RENEXC)-a randomized controlled trial.
    Zhou Y; Hellberg M; Hellmark T; Höglund P; Clyne N
    Nephrol Dial Transplant; 2021 Jan; 36(1):95-103. PubMed ID: 31848626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia.
    Woo J
    Clin Geriatr Med; 2017 Aug; 33(3):305-314. PubMed ID: 28689564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coffee treatment prevents the progression of sarcopenia in aged mice in vivo and in vitro.
    Guo Y; Niu K; Okazaki T; Wu H; Yoshikawa T; Ohrui T; Furukawa K; Ichinose M; Yanai K; Arai H; Huang G; Nagatomi R
    Exp Gerontol; 2014 Feb; 50():1-8. PubMed ID: 24269808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.